295 related articles for article (PubMed ID: 20565806)
1. SNAI2/Slug promotes growth and invasion in human gliomas.
Yang HW; Menon LG; Black PM; Carroll RS; Johnson MD
BMC Cancer; 2010 Jun; 10():301. PubMed ID: 20565806
[TBL] [Abstract][Full Text] [Related]
2. The Role Played by SLUG, an Epithelial-Mesenchymal Transition Factor, in Invasion and Therapeutic Resistance of Malignant Glioma.
Oh SJ; Ahn EJ; Kim O; Kim D; Jung TY; Jung S; Lee JH; Kim KK; Kim H; Kim EH; Lee KH; Moon KS
Cell Mol Neurobiol; 2019 Aug; 39(6):769-782. PubMed ID: 31011939
[TBL] [Abstract][Full Text] [Related]
3. microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway.
Chen DD; Cheng JT; Chandoo A; Sun XW; Zhang L; Lu MD; Sun WJ; Huang YP
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G147-G160. PubMed ID: 30943047
[TBL] [Abstract][Full Text] [Related]
4. Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma.
Shih JY; Tsai MF; Chang TH; Chang YL; Yuan A; Yu CJ; Lin SB; Liou GY; Lee ML; Chen JJ; Hong TM; Yang SC; Su JL; Lee YC; Yang PC
Clin Cancer Res; 2005 Nov; 11(22):8070-8. PubMed ID: 16299238
[TBL] [Abstract][Full Text] [Related]
5. TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth.
Di K; Linskey ME; Bota DA
Oncogene; 2013 Oct; 32(42):5038-47. PubMed ID: 23178488
[TBL] [Abstract][Full Text] [Related]
6. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
[TBL] [Abstract][Full Text] [Related]
7. The role of transcriptional coactivator TAZ in gliomas.
Li W; Dong S; Wei W; Wang G; Zhang A; Pu P; Jia Z
Oncotarget; 2016 Dec; 7(50):82686-82699. PubMed ID: 27764783
[TBL] [Abstract][Full Text] [Related]
8. Silencing of IKKε using siRNA inhibits proliferation and invasion of glioma cells in vitro and in vivo.
Li H; Chen L; Zhang A; Wang G; Han L; Yu K; Pu P; Kang C; Huang Q
Int J Oncol; 2012 Jul; 41(1):169-78. PubMed ID: 22552702
[TBL] [Abstract][Full Text] [Related]
9. Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas.
Lakka SS; Gondi CS; Dinh DH; Olivero WC; Gujrati M; Rao VH; Sioka C; Rao JS
J Biol Chem; 2005 Jun; 280(23):21882-92. PubMed ID: 15824107
[TBL] [Abstract][Full Text] [Related]
10. DSE promotes aggressive glioma cell phenotypes by enhancing HB-EGF/ErbB signaling.
Liao WC; Liao CK; Tsai YH; Tseng TJ; Chuang LC; Lan CT; Chang HM; Liu CH
PLoS One; 2018; 13(6):e0198364. PubMed ID: 29864158
[TBL] [Abstract][Full Text] [Related]
11. Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma.
Kessler T; Sahm F; Blaes J; Osswald M; Rübmann P; Milford D; Urban S; Jestaedt L; Heiland S; Bendszus M; Hertenstein A; Pfenning PN; Ruiz de Almodóvar C; Wick A; Winkler F; von Deimling A; Platten M; Wick W; Weiler M
Oncotarget; 2015 Oct; 6(31):31050-68. PubMed ID: 25682871
[TBL] [Abstract][Full Text] [Related]
12. Nobiletin inhibits invasion via inhibiting AKT/GSK3β/β-catenin signaling pathway in Slug-expressing glioma cells.
Zhang X; Zheng K; Li C; Zhao Y; Li H; Liu X; Long Y; Yao J
Oncol Rep; 2017 May; 37(5):2847-2856. PubMed ID: 28339056
[TBL] [Abstract][Full Text] [Related]
13. Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells.
Xia H; Cheung WKC; Ng SS; Jiang X; Jiang S; Sze J; Leung GKK; Lu G; Chan DTM; Bian XW; Kung HF; Poon WS; Lin MC
J Biol Chem; 2012 Mar; 287(13):9962-9971. PubMed ID: 22253443
[TBL] [Abstract][Full Text] [Related]
14. CXCR4 increases in-vivo glioma perivascular invasion, and reduces radiation induced apoptosis: A genetic knockdown study.
Yadav VN; Zamler D; Baker GJ; Kadiyala P; Erdreich-Epstein A; DeCarvalho AC; Mikkelsen T; Castro MG; Lowenstein PR
Oncotarget; 2016 Dec; 7(50):83701-83719. PubMed ID: 27863376
[TBL] [Abstract][Full Text] [Related]
15. Nuclear phosphorylated Y142 β-catenin accumulates in astrocytomas and glioblastomas and regulates cell invasion.
Náger M; Santacana M; Bhardwaj D; Valls J; Ferrer I; Nogués P; Cantí C; Herreros J
Cell Cycle; 2015; 14(22):3644-55. PubMed ID: 26654598
[TBL] [Abstract][Full Text] [Related]
16. CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling.
Wang Y; Wang Y; Li J; Zhang Y; Yin H; Han B
Cancer Lett; 2015 Oct; 367(2):122-8. PubMed ID: 25813405
[TBL] [Abstract][Full Text] [Related]
17. MDA-9/syntenin is a key regulator of glioma pathogenesis.
Kegelman TP; Das SK; Hu B; Bacolod MD; Fuller CE; Menezes ME; Emdad L; Dasgupta S; Baldwin AS; Bruce JN; Dent P; Pellecchia M; Sarkar D; Fisher PB
Neuro Oncol; 2014 Jan; 16(1):50-61. PubMed ID: 24305713
[TBL] [Abstract][Full Text] [Related]
18. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2.
Liao H; Bai Y; Qiu S; Zheng L; Huang L; Liu T; Wang X; Liu Y; Xu N; Yan X; Guo H
Oncotarget; 2015 Apr; 6(11):8914-28. PubMed ID: 25871397
[TBL] [Abstract][Full Text] [Related]
19. KITENIN promotes glioma invasiveness and progression, associated with the induction of EMT and stemness markers.
Lee KH; Ahn EJ; Oh SJ; Kim O; Joo YE; Bae JA; Yoon S; Ryu HH; Jung S; Kim KK; Lee JH; Moon KS
Oncotarget; 2015 Feb; 6(5):3240-53. PubMed ID: 25605251
[TBL] [Abstract][Full Text] [Related]
20. Knock down of HIF-1alpha in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres.
Méndez O; Zavadil J; Esencay M; Lukyanov Y; Santovasi D; Wang SC; Newcomb EW; Zagzag D
Mol Cancer; 2010 Jun; 9():133. PubMed ID: 20515450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
